Recognising the urgent need to understand the resistance mechanisms underlying glioblastoma (GBM), the EU-driven Horizon 2020 TRANSCAN-3 programme has decided to fund a multinational project coordinated by LIH’s NORLUX group.
Copy and paste this URL into your WordPress site to embed
